TOMORROW, 1/29! Fourth Annual Health Law Year in P/Review Symposium


MORE SEATS AVAILABLE! Fourth Annual Health Law Year in P/Review
January 29, 2016 8:00 AM – 5:00 PM
Wasserstein Hall, Milstein West AB 
Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA

The Fourth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during 2015 and what to watch out for in 2016. The discussion at this day long event will cover hot topics in such areas as health insurance, health care systems, public health, innovation, and other issues facing clinicians and patients.

In addition to presenting at the conference, many of our speakers will write about their topics for a collaborative blog series that will begin in February 2016 on the Health Affairs Blog.

This year’s Health Law Year in P/Review is sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, the New England Journal of MedicineHealth Affairs, the Hastings CenterHarvard Health Publications at Harvard Medical School, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund at Harvard University.

Agenda

Each speaker’s presentation will be followed by time for Q & A.

8:00 – 8:30am, Registration

Breakfast will be available.

8:30 – 8:35am, Welcome Remarks

8:35 – 9:00am, The Current State of Health Care Reform

  • Abigail Moncrieff, Peter Paul Career Development Professor and Associate Professor of Law, Boston University School of Law

9:00 – 9:25am, Medicaid Expansion

9:25 – 9:50am, Value-Based Health Care Payment

  • Michael Chernew, Leonard D. Schaeffer Professor of Health Care Policy and Director of the Healthcare Markets and Regulation (HMR) Lab, Department of Health Care Policy, Harvard Medical School

9:50 – 10:15am, 2016 Presidential Election and Health Policy

10:15 – 10:30am, Break

10:30 – 10:55am, Proposed Amendments to the Common Rule Governing Human Subjects Research

  • Barbara E. Bierer, Faculty Co-Director, Multi-Regional Clinical Trials Center of Harvard and Brigham and Women’s Hospital; Director, Regulatory Foundations, Ethics and the Law Program, Harvard Catalyst, Harvard Medical School; Professor of Medicine, Harvard Medical School; Senior Physician, Division of Global Health Equity, Department of Medicine, Brigham and Women’s Hospital

10:55 – 11:20am, Expanded Access for Individuals and Right to Try Laws

11:20 – 11:45am, Fetal Tissue Research and Controversy

  • I. Glenn Cohen, Professor of Law, Harvard Law School, and Faculty Director, Petrie-Flom Center

11:45am – 12:10pm, Wellness Incentives and the ADA

  • Kristin Madison, Professor of Law and Health Sciences, Northeastern University School of Law

12:10 – 12:30pm, Break to Pick Up Lunch

Lunch will be provided.

12:30 – 1:30pm, Debate: Information Sharing or Misleading Promotion? Evolving Case Law on Pharmaceutical Company Statements

  • Jerry Avorn, Professor of Medicine, Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
  • James M. (Mit) Spears, Executive Vice President and General Counsel, The Pharmaceutical Research and Manufacturers of America (PhRMA)

1:30 – 1:40pm, Break

1:40 – 2:05pm, 21st Century Cures

  • Aaron Kesselheim, Associate Professor of Medicine, Harvard Medical School and faculty member, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital

2:05 – 2:30pm, Trade Law’s Impact on Health Law

  • Amy Kapczynski, Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School

2:30 – 3:00pm, Health IP Update

3:00 – 3:25pm, Antitrust and Health Law

  • Barak Richman, Edgar P. and Elizabeth C. Bartlett Professor of Law and Professor of Business Administration, Duke University

3:25 – 3:35pm, Break

3:35 – 4:00pm, Gun Control and Public Health Law

  • Wendy Parmet, Matthews Distinguished University Professor of Law, Professor of Public Policy and Urban Affairs, Director of the Program on Health Policy, and Law and Associate Dean for Interdisciplinary Education and Research Support at Northeastern University School of Law

4:00 – 4:25pm, Opioid Addiction

  • Rebecca Haffajee, Thomas O. Pyle Fellow in Pharmaceutical Policy Research, Department of Population Medicine, Harvard Pilgrim Healthcare Institute

4:25 – 5:00pm, #Blacklivesmatter and Health Law

  • David R. Williams, Florence Sprague Norman and Laura Smart Norman Professor of Public Health, Department of Social and Behavioral Sciences, Harvard T. H. Chan School of Public Health

5:00pm, Adjourn

Registration

This event is free and open to the public, but registration is required. Register now!

Partner Event

Don’t miss more great discussion of issues in health law policy and bioethics at the the American Journal of Law and Medicine‘s annual symposium!

Global Infectious Diseases: New Challenges and Solutions

Saturday, January 30, 2016, 8:15am – 5:00pm

Boston University School of Law

Infectious diseases were once relegated to the dustbin of history, but today emerging and re- emerging infectious diseases threaten health and health care systems in every country. Issues include whether we are blundering into a post-antibiotic apocalypse; how to prevent the emergence of global infectious diseases; and how to ensure equitable access to appropriate prevention and therapies across all income groups.

Recent events, such as the measles outbreak in the United States, the Ebola epidemic in West Africa, and litigation over a compounding pharmacy’s liability in the spread of fungal meningitis, highlight the legal, medical, and bioethical challenges posed by infectious diseases. This symposium will focus on the interdisciplinary considerations and obstacles raised by these and similar developments. Panels will discuss challenges and constraints to developing new treatments for infectious diseases, the global challenge of addressing diseases that do not recognize national borders, responsibilities relating to vaccination, the development of “super bugs” due to excessive use of antibiotics, and the possibility of expanding tort liability to cover the spread of infectious diseases.

For more information, visit the website!